Skip to main content
CVHIF logo

Ventura Cannabis & Wellness Corporation (CVHIF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 56.0K| 52-wk range: $0.000001 – $0.0001

Beta 2.96: the stock has moved about 196% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Ventura Cannabis & Wellness Corporation (CVHIF) trades at $0.0001. Ventura Cannabis & Wellness Corporation is a vertically integrated cannabis product company operating in California. The company focuses on producing and distributing cannabis products within the state's regulated market. Sector: Healthcare.

Price as of · Last analyzed: Mar 17, 2026
Ventura Cannabis & Wellness Corporation is a vertically integrated cannabis product company operating in California. The company focuses on producing and distributing cannabis products within the state's regulated market.

Analyst Coverage for CVHIF: CVHIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the CVHIF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Ventura Cannabis & Wellness Corporation (CVHIF) Healthcare & Pipeline Overview

CEOPablo Mendez
HeadquartersLos Angeles, US
IPO Year2015

Ventura Cannabis & Wellness Corporation is a vertically integrated cannabis company in California, focusing on the production and distribution of cannabis products. Operating in a competitive market, the company faces challenges and opportunities related to regulatory changes and market expansion within the state's cannabis industry.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CVHIF?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Investing in Ventura Cannabis & Wellness Corporation presents both opportunities and risks. The company's vertical integration could lead to higher profit margins and better quality control compared to companies focusing on a single aspect of the cannabis business. However, the company's negative profit margin of -16.2% raises concerns about its financial stability and operational efficiency. The high beta of 2.96 indicates significant volatility, making it a higher-risk investment. Growth catalysts include potential regulatory changes in California that could expand the market and increased consumer acceptance of cannabis products. The company's ability to scale its operations and establish a strong brand will be crucial for long-term success. Investors should carefully consider the company's financial performance, competitive landscape, and regulatory environment before investing.

Based on FMP financials and quantitative analysis

CVHIF Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Ventura Cannabis & Wellness Corporation operates as a vertically integrated cannabis product company in California.

  • The company reported a negative profit margin of -16.2%, indicating potential financial challenges.
  • Gross margin stands at 29.7%, reflecting the company's ability to generate revenue after accounting for the cost of goods sold.
  • The company's beta of 2.96 suggests high volatility compared to the overall market.
  • Ventura Cannabis & Wellness Corporation does not currently offer a dividend.

Who Are CVHIF's Competitors?

CVHIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AKAN Akanda Corp. $1.98 -10.41% —
APUS Apimeds Pharmaceuticals US, Inc. $5.03 +56.21% $7.59M —
BFRI Biofrontera Inc. $0.89 -12.23% $11.4M —
COSM COSM $0.38 -1.58% $20.7M —
QNTM Quantum BioPharma Ltd. $3.27 -4.94% $20.9M —
AYTU Aytu BioPharma, Inc. $2.04 -1.45% $21.9M —
TXMD TherapeuticsMD, Inc. $2.08 +1.22% $24.0M —
CPHI CPHI $0.67 +1.57% $27.0M —

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CVHIF's Key Strengths?

Vertically integrated operations.

  • Established presence in the California cannabis market.
  • Potential for strong brand recognition.
  • Expertise in navigating the regulatory landscape.

What Are CVHIF's Weaknesses?

Negative profit margin.

  • High beta indicating high volatility.
  • Limited financial resources compared to larger competitors.
  • Dependence on the California market.

What Are the Key Risks for CVHIF?

Negative return on equity (-26.1%) — the business is not currently generating profit on shareholder capital.

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Intense competition from other cannabis companies in California.
  • Evolving regulations and potential changes in the legal framework.
  • Taxation and compliance costs.
  • Competition from the illicit cannabis market.
  • Negative profit margin and financial instability.

What Are CVHIF's Competitive Advantages?

  • Vertical Integration: Controlling the entire supply chain from cultivation to retail can lead to cost advantages and quality control.
  • Brand Recognition: A strong brand presence in the California cannabis market can attract and retain customers.
  • Regulatory Compliance: Expertise in navigating the complex regulatory landscape can create a barrier to entry for new competitors.

What Does CVHIF Do?

Ventura Cannabis & Wellness Corporation, formerly known as BLVD Centers Corporation, was incorporated in 2013 and rebranded in February 2019 to reflect its focus on the cannabis industry. Headquartered in Los Angeles, California, the company operates as a vertically integrated cannabis product company. This means Ventura Cannabis & Wellness Corporation is involved in various stages of the cannabis supply chain, potentially including cultivation, processing, manufacturing, distribution, and retail. The company's business model allows it to control the quality and cost of its products, from seed to sale. Operating within the California cannabis market, Ventura Cannabis & Wellness Corporation navigates a complex regulatory landscape while striving to establish a strong brand presence and capture market share. The company aims to capitalize on the growing demand for cannabis products in California by offering a range of cannabis-derived goods to consumers.

What Products and Services Does CVHIF Offer?

  • Cultivates cannabis plants.
  • Processes raw cannabis into various products.
  • Manufactures cannabis-infused products like edibles and topicals.
  • Distributes cannabis products to retail locations.
  • Operates retail dispensaries.
  • Engages in branding and marketing activities to promote its products.

How Does CVHIF Make Money?

  • Vertically integrated operations from cultivation to retail.
  • Generates revenue through the sale of cannabis products.
  • Focuses on the California cannabis market.

What Industry Does CVHIF Operate In?

Ventura Cannabis & Wellness Corporation operates within the rapidly evolving cannabis industry in California. The market is characterized by increasing consumer demand, evolving regulations, and intense competition. Companies like Ventura Cannabis & Wellness Corporation must navigate a complex legal framework while striving to differentiate themselves through product innovation, branding, and operational efficiency. The industry is experiencing significant growth, driven by changing societal attitudes and the increasing legalization of cannabis for medical and recreational use. However, companies also face challenges such as regulatory uncertainty, taxation, and competition from both legal and illegal operators. Competitors include BZAMF (BZAM Ltd.), EMGE (Emerald Green Group Inc.), NLVVF (Nulife Ventures Inc.), NMRD (Nutraceutical Merchandising Inc.), and NMXS (Numinus Wellness Inc.).

Who Are CVHIF's Key Customers?

  • Adult-use cannabis consumers in California.
  • Medical cannabis patients with prescriptions.
  • Retail dispensaries that carry Ventura Cannabis & Wellness Corporation products.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Ventura Cannabis & Wellness Corporation operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Pablo Mendez. CVHIF has traded publicly since 2015.

ROE -26%

Key Financial Metrics

Return on equity for Ventura Cannabis & Wellness Corporation stands at -26.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -14.4%, showing how much profit it generates from its asset base. A current ratio of 2.39 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 2/9

Financial Health

Ventura Cannabis & Wellness Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

CVHIF Financials

Fundamental Snapshot

Return on Equity (TTM)
-26.1%
Current Ratio
2.4

Based on FMP financials and quantitative analysis

CVHIF Latest News

CVHIF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CVHIF.

Price Targets

Wall Street price target analysis for CVHIF.

CVHIF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CVHIF; grades run from A+ (80-100) to F (below 30).

Leadership: Pablo Mendez

CEO

Without access to additional sources, it is impossible to provide details on his career history, education, or previous roles. Further research would be required to create a comprehensive profile of Mr. Mendez's professional background.

Track Record: Information on Pablo Mendez's track record is not available in the provided data. Without access to additional sources, it is impossible to provide details on his key achievements, strategic decisions, or company milestones under his leadership. Further research would be required to assess his performance as CEO of Ventura Cannabis & Wellness Corporation.

CVHIF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Ventura Cannabis & Wellness Corporation may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the lack of transparency and potential for fraud or manipulation. These companies are not required to be SEC reporting.

  • OTC Tier: OTC Other
Liquidity: Liquidity for stocks on the OTC Other tier can be highly variable and often limited. Bid-ask spreads can be wide, and trading volume may be low, making it difficult to buy or sell shares quickly or at a desired price. Investors may experience significant price fluctuations and may not be able to execute large trades without impacting the market price. This lack of liquidity increases the risk of investing in Ventura Cannabis & Wellness Corporation.
OTC Risk Factors:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Higher risk of fraud or scams.
  • Limited regulatory oversight.
Due Diligence Checklist:
  • Verify the company's registration and licensing.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Research the background and experience of the company's management team.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
  • Check for any regulatory actions or legal proceedings against the company.
Legitimacy Signals:
  • Company has been in operation since 2013.
  • Company is headquartered in Los Angeles, California.
  • Company operates in the regulated cannabis market in California.

Common Questions About CVHIF (Healthcare)

What do analysts say about CVHIF stock?

There is currently no analyst coverage available for Ventura Cannabis & Wellness Corporation (CVHIF). This lack of coverage may be due to the company's small market capitalization and its listing on the OTC Other tier.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on OTC-listed companies.
  • Lack of analyst coverage for CVHIF.
  • Financial data may be outdated or incomplete.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis